tirzepatide shortage over Compounded Crisis! Patients Left Scrambling as FDA Ends Compounders protest as FDA removes
Description
Semaglutide aids weight loss by reducing appetite and slowing digestion

Rybelsus 14mg tablet is an oral GLP-1 receptor agonist containing semaglutide, used to manage type 2 diabetes and improve blood sugar levels effectively.

#glp1 #diabetes #medication #T2DM | 28 comments on LinkedIn
Discover how this first-in-class oral GLP-1 receptor agonist works for type 2 diabetes, its FDA-approved uses, clinical benefits, and essential safety information for patients and providers.

Big pharma is currently facing a potential bubble effect due to the surging demand for weight loss and diabetes drugs, as revealed in a report by Deloitte released on Monday

Further studies in models more closely reflecting type 2 diabetes are warranted to clarify the underlying mechanisms and translational relevance
